title: Functional role of peripheral opioid receptors in the regulation of cardiac spinal afferent nerve activity during myocardial ischemia.
abstract: Thinly myelinated Aδ-fiber and unmyelinated C-fiber cardiac sympathetic (spinal) sensory nerve fibers are activated during myocardial ischemia to transmit the sensation of angina pectoris. Although recent observations showed that myocardial ischemia increases the concentrations of opioid peptides and that the stimulation of peripheral opioid receptors inhibits chemically induced visceral and somatic nociception, the role of opioids in cardiac spinal afferent signaling during myocardial ischemia has not been studied. The present study tested the hypothesis that peripheral opioid receptors modulate cardiac spinal afferent nerve activity during myocardial ischemia by suppressing the responses of cardiac afferent nerve to ischemic mediators like bradykinin and extracellular ATP. The nerve activity of single unit cardiac afferents was recorded from the left sympathetic chain (T₂-T₅) in anesthetized cats. Forty-three ischemically sensitive afferent nerves (conduction velocity: 0.32-3.90 m/s) with receptive fields in the left and right ventricles were identified. The responses of these afferent nerves to repeat ischemia or ischemic mediators were further studied in the following protocols. First, epicardial administration of naloxone (8 μmol), a nonselective opioid receptor antagonist, enhanced the responses of eight cardiac afferent nerves to recurrent myocardial ischemia by 62%, whereas epicardial application of vehicle (PBS) did not alter the responses of seven other cardiac afferent nerves to ischemia. Second, naloxone applied to the epicardial surface facilitated the responses of seven cardiac afferent nerves to epicardial ATP by 76%. Third, administration of naloxone enhanced the responses of seven other afferent nerves to bradykinin by 85%. In contrast, in the absence of naloxone, cardiac afferent nerves consistently responded to repeated application of ATP (n = 7) or bradykinin (n = 7). These data suggest that peripheral opioid peptides suppress the responses of cardiac sympathetic afferent nerves to myocardial ischemia and ischemic mediators like ATP and bradykinin.
authors: Department of Medicine, School of Medicine, University of California, Irvine, CA 92697, USA. lwfu@uci.edu
authors: Liang-Wu
authors: LW
authors: Fu
authors: John C
authors: JC
authors: Longhurst
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000344:Afferent Pathways / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D006352:Heart Ventricles / Q000294:innervation*; D017202:Myocardial Ischemia / Q000378:metabolism / Q000503:physiopathology*; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009431:Neural Conduction / Q000187:drug effects*; D013127:Spinal Nerves / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone; D000255:Adenosine Triphosphate; D001920:Bradykinin
keywords: myocardial ischemia; naloxone; opioid receptors; sympathetic afferent nerves
references: Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10340-10345
references: 16801531
references: Sheng Li Xue Bao. 2001 Jun;53(3):205-8
references: 12589405
references: J Pharmacol Exp Ther. 1995 Dec;275(3):1535-42
references: 8531126
references: Mol Cell Endocrinol. 1987 Jan;49(1):1-16
references: 2435586
references: Eur Heart J. 1992 Aug;13(8):1074-9
references: 1354615
references: Brain Res Mol Brain Res. 1998 Oct 1;60(2):160-7
references: 9757025
references: Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R276-83
references: 17491115
references: Proc Natl Acad Sci U S A. 1987 Aug;84(15):5487-91
references: 2440052
references: Jpn Heart J. 2004 May;45(3):365-71
references: 15240957
references: J Physiol. 2010 Jul 1;588(Pt 13):2473-86
references: 20442267
references: Brain. 2007 Feb;130(Pt 2):502-13
references: 17142830
references: Clin Neuropharmacol. 1991 Apr;14(2):131-47
references: 1849794
references: Handb Exp Pharmacol. 2009;(194):185-225
references: 19655108
references: J Physiol. 2002 Nov 1;544(3):897-912
references: 12411532
references: Neuroscience. 1993 Jul;55(1):185-95
references: 7688879
references: J Neurosci. 1994 Jun;14(6):3842-51
references: 8207492
references: Neuropharmacology. 2005 Apr;48(5):639-47
references: 15814099
references: Brain Res Rev. 2009 Apr;60(1):90-113
references: 19150465
references: Am Heart J. 1998 May;135(5 Pt 1):813-8
references: 9588410
references: Ann N Y Acad Sci. 2001 Jun;940:74-95
references: 11458709
references: J Neuroimmune Pharmacol. 2006 Mar;1(1):90-7
references: 18040794
references: J Neuroimmunol. 2001 Apr 2;115(1-2):71-8
references: 11282156
references: J Physiol. 1999 Aug 1;518 ( Pt 3):857-66
references: 10420020
references: Brain Res. 1994 Feb 14;636(2):286-97
references: 8012813
references: J Auton Nerv Syst. 1981 Apr;3(2-4):231-6
references: 7276432
references: Brain Res. 1997 Aug 1;764(1-2):126-32
references: 9295201
references: Brain Res. 1989 Sep 18;497(2):231-8
references: 2573404
references: Circ Res. 2003 Jun 27;92(12):1359-66
references: 12775581
references: Nature. 1980 Mar 27;284(5754):351-3
references: 6244504
references: Pain. 1999 Feb;79(2-3):175-85
references: 10068163
references: Neuroscience. 1994 Feb;58(4):793-8
references: 8190256
references: Am J Physiol. 1986 Aug;251(2 Pt 2):H314-23
references: 3740286
references: Am J Physiol. 1998 Aug;275(2):H378-84
references: 9683423
references: Annu Rev Immunol. 2009;27:165-97
references: 19302038
references: Pain. 2001 Jan;89(2-3):221-7
references: 11166478
references: Auton Neurosci. 2001 Jun 20;89(1-2):38-47
references: 11474645
references: Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1762-71
references: 20870803
references: Neurogastroenterol Motil. 2004 Oct;16 Suppl 2:29-37
references: 15357849
references: Brain Res Mol Brain Res. 1995 Jun;30(2):203-10
references: 7543648
references: J Neurophysiol. 2000 Apr;83(4):2209-16
references: 10758129
references: Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3627-35
references: 17890425
references: Physiol Rev. 2007 Apr;87(2):659-797
references: 17429044
references: Pharmacol Rev. 2005 Mar;57(1):27-77
references: 15734727
references: Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2530-40
references: 18952714
references: Neurogastroenterol Motil. 2000 Dec;12(6):517-22
references: 11123706
references: Annu Rev Pharmacol Toxicol. 2000;40:389-430
references: 10836142
references: Circulation. 1994 Jan;89(1):36-44
references: 8281670
references: Neuroscience. 1989;32(3):571-5
references: 2557556
references: J Pharmacol Exp Ther. 1989 Mar;248(3):1269-75
references: 2539460
references: J Neurophysiol. 2005 Feb;93(2):713-22
references: 15653785
references: J Neurophysiol. 2006 Apr;95(4):2083-97
references: 16339007
references: J Pharmacol Exp Ther. 2007 Jun;321(3):839-47
references: 17347322
references: J Physiol. 1998 Jul 15;510 ( Pt 2):633-41
references: 9706010
references: Am J Physiol. 1995 Sep;269(3 Pt 2):H888-901
references: 7573532
references: Proc Natl Acad Sci U S A. 1990 Aug;87(15):5935-9
references: 1974052
references: Am J Physiol Regul Integr Comp Physiol. 2012 Apr;302(7):R833-44
references: 22204951
references: Am J Physiol Heart Circ Physiol. 2010 Jan;298(1):H235-44
references: 19897709
references: J Neurosci. 1999 Oct 1;19(19):8337-48
references: 10493735
references: Mol Pain. 2006 Jul 16;2:22
references: 16842630
references: Circulation. 2000 Jun 27;101(25):2883-8
references: 10869258
references: J Neurosci. 2005 Sep 28;25(39):8825-32
references: 16192372
references: J Physiol. 1980 Sep;306:519-36
references: 7463375
references: J Neurosci. 1995 Dec;15(12):8156-66
references: 8613750
references: Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G963-70
references: 18258789
references: J Clin Neurophysiol. 1997 Jan;14(1):2-31
references: 9013357
references: Am J Physiol. 1974 May;226(5):1094-9
references: 4824862
references: Clin Exp Pharmacol Physiol. 1995 Nov;22(11):812-6
references: 8593735
references: Neurosci Lett. 1987 Apr 23;76(1):107-12
references: 2884605
references: J Physiol. 2008 Jul 1;586(13):3287-300
references: 18483073
references: J Neurosci. 2006 Jan 18;26(3):953-62
references: 16421315